Agilent Technologies A
NYSE A
$156.34 +2.65 (+1.72%)
As of: Sep 17, 2026 · 3:59 PM EDT

Agilent Technologies (A) Cash from Financing Activities (2009 - 2026)

Agilent Technologies' (A) quarterly Cash from Financing Activities came in at $471.0 million in Q3 2026, up 315.07% year-over-year from $113.5 million in Q3 2025, and up 427.08% quarter-over-quarter from -$144.0 million in Q2 2026.

Analysis

Agilent Technologies (A) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Agilent Technologies (A) has reported Cash from Financing Activities for 18 consecutive years, with $471.0 million the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Cash from Financing Activities rose 315.07% year-over-year to $471.0 million in Q3 2026; TTM through Jul 2026 was -$95.0 million, a 80.61% increase from a year earlier, with the FY2025 full-year figure at -$715.0 million, up 4.92% from the prior year.
  • Cash from Financing Activities was $471.0 million for Q3 2026 at Agilent Technologies, up from -$144.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $471.0 million in Q3 2026 and troughed at -$546.0 million in Q1 2022.
  • A 5-year average of -$192.8 million and a median of -$219.0 million in 2025 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities slumped 1311.76% in 2024 and surged 315.07% in 2026, its largest moves.
  • Over 5 years, Cash from Financing Activities stood at -$341.0 million in 2022, then soared by 41.06% to -$201.0 million in 2023, then surged by 112.44% to $25.0 million in 2024, then plunged by 900.0% to -$200.0 million in 2025, then soared by 335.5% to $471.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at $471.0 million (Q3 2026), -$144.0 million (Q2 2026), and -$222.0 million (Q1 2026), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -1.57 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 7.27 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 471.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -129.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -23.16 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -33.21 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -27.60 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -6.20 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 3.02 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 149.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 471.00 Mn
Apr 30, 2026 -144.00 Mn
Jan 31, 2026 -222.00 Mn
Oct 31, 2025 -200.00 Mn
Jul 31, 2025 -219.00 Mn
Apr 30, 2025 -116.00 Mn
Jan 31, 2025 -180.00 Mn
Oct 31, 2024 25.00 Mn
Jul 31, 2024 -246.00 Mn
Apr 30, 2024 -291.00 Mn
Jan 31, 2024 -240.00 Mn
Oct 31, 2023 -201.00 Mn
Jul 31, 2023 -322.00 Mn
Apr 30, 2023 -390.00 Mn
Jan 31, 2023 -17.00 Mn
Oct 31, 2022 -341.00 Mn
Jul 31, 2022 -362.00 Mn
Apr 30, 2022 -123.00 Mn
Jan 31, 2022 -546.00 Mn
Oct 31, 2021 -324.00 Mn